The role of the occupational physician in substance abuse

Occupational Medicine - State of the Art Reviews

Volumn 17, Issue 1, 2002, Pages 1-12

  Lambert, Susan D ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845328490     PISSN: 0885114X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. ACOEM: Code of Ethical Conduct. Adopted October 25, 1993 by the Board of Directors of the American College of Occupational and Environmental Medicine. Updated October 21, 1997.
2. American Society of Addiction Medicine. Patient Placement Criteria, 2nd ed. revised. Chevy Chase, Maryland, American Society of Addiction Medicine, 2001.
3. An Analysis of Worker Drug Use and Workplace Policies and Programs. Substance Abuse and Mental Health Services Administration (SAMHSA), DHHS Publication Number (SMA)97-3142, 1997.
4. Anfield RN: Americans with Disabilities Act of 1990: A primer of Title I provisions for occupational health care professionals. J Occup Med 34(5):503-509, 1992.
5. Batki SL: Drug abuse, psychiatric disorders, and AIDS: Dual and triple diagnosis. Western J Med 152(5):547-552, 1990.
6. Bell NS, Mangione TW, Howland J, et al: Worksite barriers to the effective management of alcohol problems. J Occup Environ Med 38(12):1213-1219, 1996.
7. California Assembly Bill (AB) 2222. Effective January 1, 2001.
8. Cassel J: The contribution of the social environment to host resistance. Am J Epi 104(2):107-123, 1976.
9. Clark HW: The role of physicians as Medical Review Officers in workplace drug testing programs: In pursuit of the last nanogram. Western J Med 152(5):514-524, 1990.
10. Committee Report: ACOEM Committee on Ethical Practice in Occupational Medicine. Commentaries on the Code of Ethical Conduct. 1. J Occup Environ Med 37(2):201-206, 1995.
11. Committee Report: Council on Social Issues (ACOM). Drug screening in the workplace: Ethical guidelines. J Occup Med 33(5):651-652, 1991.
12. Conti DJ, Burton WN: The economic impact of depression in a workplace. J Occup Med 36(9):983-988, 1994.
13. Di Clemente CE, Prochaska J: Toward a comprehensive transtheoretical model of change: Stages of change and addictive behaviors. In Miller WR, Heather N (eds): Treating Addictive Behaviors: Processes of Change, 2nd ed. New York, Plenum Press, 1998, pp 3-24.
14. Druss B, Rosenheck R, Sledge W: Health and disability costs of depressive illness in a major US corporation. Am J Psychiatry 157:1274-1278, 2000.
15. Equal Employment Opportunity Commission. A Technical Assistance Manual on the Employment Provisions (Title I) of the Americans with Disabilities Act. Washington, DC, US Government Printing Office, 1992.
16. Federal Register. Volume 65, No. 244, December 19, 2000, 49 CFR Part 40, 2000.
17. Greenberg P, Stiglin L, Finkelstein S, Berndt E: The economic burden of depression in 1990. J Clin Psychiatry 54:405-418, 1993.
18. Himmelstein JS, Pransky GS: The ADA and you: Implications for the occupational health professional (editorial). J Occup Med 34(5):501-502, 1992.
19. Leshner A: Addiction is a brain disease, and it matters. Science 278:45-47, 1997.
20. Ling W, Wesson DR: Drugs of abuse-opiates. Western J Med 152 (5):565-572, 1990.
21. Lundberg G: Mandatory unindicated urine drug screening: Still chemical McCarthyism. JAMA 256:3005, 1986.
22. Mandatory guidelines for federal workplace testing programs: Final guidelines. Federal Register 53:11970-11989, 1988.
23. McDowell DM, Clotfelter RC: Depression and substance abuse: Considerations of etiology, comorbidity, evaluation, and treatment. Psychiatr Ann 31(4):244-251, 2001.
24. Miller WR: Enhancing Motivation for Change in Substance Abuse Treatment: Treatment Improvement Protocol (TIP) Series. 35. US Department of Health and Human Services, Public Health Service, SAMHSA, Center for Substance Abuse Treatment, Rockville, MD [DHHS Publication No. (SMA) 99-3354], 1999.
25. Miller WR, Rollnick S: Motivational interviewing: Preparing people to change addictive behavior. New York, Guilford, 1991.
26. Moyers PA, Stoffel VC: Alcohol dependence in a client with a work-related injury. Am J Occup Ther 53(6):640-645, 1999.
27. Myrick H, Brady K: Management of comorbid anxiety and substance use disorders. Psychiatr Ann 31(4):265-271, 2001.
28. Osterloh JD, Becker CE: Chemical dependency and drug testing in the workplace. Western J Med 152(5):506-513, 1990.
29. Procedures for transportation workplace drug and alcohol testing programs. Final rule. 29 CFR Part 40, Federal Register, 65(244):79461-79510, 2000.
30. Procedures for transportation workplace drug testing programs. Final rule. 29 CFR Part 40, Federal Register 54(230):49854-49884, 1989.
31. Roman PM, Trice HM: The development of deviant drinking behavior: Occupational risk factors. Arch Environ Health 20:424-435, 1970.
32. Rosenstock L, Cullen MR: Routine urine testing for evidence of drug abuse in workers: The scientific, ethical and legal reasons not to do it. J Gen Intern Med 2(2):135-137, 1987.
33. Ryan J, Zwerling C, Jones M: The effectiveness of preemployment drug screening in the prediction of employment outcome. J Occup Med 34(11):1057-1063, 1992.
34. Schweigert MK, Ritter CJ, MacKenzie D: The application of Ontario human rights legislation to the practice of occupational medicine. Occup Med 50(5):348-352, 2000.
35. Stansfeld S, Feeney A, Head J, et al: Sickness absence for psychiatric illness: The Whitehall II Study. Soc Sci Med 40:189-197, 1995.
36. St. Clair S, Shultz T: Americans with Disabilities Act: Considerations for the practice of occupational medicine. J Occup Med 34(5):510-517, 1992.
37. Straus R, Bacon SD: Alcoholism and social stability: A study of occupational integration in 2,023 male clinic patients. Q J Stud Alcohol 12:231-260, 1951.
38. Summary of Findings from the 1999 National Household Survey on Drug Abuse. SAMHSA, DHHS Publication Number (SMA) 00-3466, 2000.
39. Tashkin DP: Pulmonary complications of smoked substance abuse. Western J Med 152(5):525-530, 1990.
40. Worker Drug Use and Workplace Policies and Programs. Results from the 1994 and 1997 NHSDA, SAMHSA, DHHS Publication Number (SMA) 99-3252, 1999.
41. Zwerling C, Ryan J: Preemployment drug screening: The epidemiologic issues. J Occup Med 34(6):595-599, 1992.
42. Zwerling C, Ryan J, Orav EJ: The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA 264(20):2639-2643, 1990.